Article
Ryanodine receptor type 1 (RyR1) possessing malignant hyperthermia mutation R615C exhibits heightened sensitivity to dysregulation by non-coplanar 2,2',3,5',6-pentachlorobiphenyl (PCB 95).
Neurotoxicology - 1 Jul 2007
Ta Tram Anh, Pessah Isaac N
Abstract excerpt
Malignant hyperthermia (MH) susceptibility is conferred by inheriting one of >60 missense mutations within the highly regulated microsomal Ca(2+) channel known as ryanodine receptor type 1 (RyR1). Although MH susceptible patients lack overt clinical signs, a potentially lethal MH syndrome can be...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
